Obesity drug Qsymia, which is manufactured by California pharmaceutical company Vivus, has been cleared for consumption by the masses. This marks the second weight-loss drug to get the stamp of approval from the Food and Drug Administration in just under two months. Although the pills are supposed to be an effective way for people to shed pounds, some doctors have instructed their patients to play the waiting game before offering up prescriptions.
“I’ll probably take a wait-and-see attitude myself,” explained Greg Anderson, an assistant professor of family medicine at the Mayo Clinic. “The track record has not been particularly good for diet medications.” Although some doctors have expressed similar concerns regarding the Qsymia and its like-minded cohort, Belviq, some physicians believe these medications can help people get started by providing immediate results.
“Once the patient has learned how to control the appetite and has lost a good amount of weight, she or he is stimulated to continue to lose weight without the medications,” said Dr. Albert Levy, who is an assistant professor of medicine at the Mount Sinai School of Medicine.
Watch these videos about the new, exciting diet drug!
Popularity: 1% [?]